Amy Judd Lieberman, J.D., is a senior attorney with the Harm Reduction Legal Project. Before joining the Project, Amy worked briefly in litigation after a fellowship with the National Health Law Program (NHeLP) working on critical issues related to the opioid epidemic and promoting harm reduction practices, specifically in the communities served by Medicaid and Medi-cal. While in law school, she was the president of the Law Students for Sensible Drug Policy chapter, spearheading efforts to educate law students and the community on humane drug policy and harm reduction. She was also an advocate on the Jessup International Moot Court team and a research editor for the UC Irvine Law Review, and she received awards for her pro bono work and her work in the International Justice Clinic, supporting the mandate of the United Nations Special Rapporteur on the promotion and protection of the right to freedom of opinion and expression. Amy received her B.F.A from New York University and her J.D. from the University of California, Irvine School of Law. She is barred in California and the United States District Court for the Central District of California.
This paper identifies barriers to OAT access and potential solutions to improve OAT uptake in eight sectors.
This survey of state laws outlines how the legal landscape in each state may affect access to harm reduction services and supplies.
Drug overdose continues to claim the lives of tens of thousands of people in the U.S. every year. Opioids, both prescription painkillers and street drugs such as heroin and illicitly manufactured fentanyl, are responsible for the majority of these deaths. In response, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws.
In this Q&A, Corey Davis, deputy director of the Network’s Southeastern Region Office and director of the Network’s Harm Reduction Legal Project; and Amy Lieberman, senior attorney, for the Network’s Harm Reduction Legal Project, discuss some of the key elements in the chapter they authored, Access to Care for Individuals with Opioid Use Disorder, for the Report.
This webinar focused on the legal and regulatory modifications during COVID-19, how they are being used to increase access treatment for opioid use disorder, and opportunities to permanently increase access to medications.
While states have passed various laws designed to increase access to naloxone, a life-saving opioid overdose reversal medication, none explicitly address the legality of dispensing naloxone that is past its expiration date. This fact sheet discusses whether Georgia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.
This fact sheet discusses whether District of Columbia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.
Overview Death and other negative impacts from drug overdose in general, and opioid overdose specifically,…
This fact sheet discusses whether Illinois laws forbids the prescription, dispensing, distribution, possession, or administration of expired naloxone.
This fact sheet discusses whether Illinois laws forbids the prescription, dispensing, distribution, possession, or administration of expired naloxone.
For a variety of reasons, individuals under the age of 18 may wish to access naloxone without knowledge of their parent or guardian. This fact sheet discusses whether it is permissible to prescribe naloxone to minors in Pennsylvania.
To address the legal and policy barriers that hamper the establishment and expansion of evidence-based harm reduction measures, the Network for Public Health Law has launched the Harm Reduction Legal Project with support from Arnold Ventures.
